NLRP3 and Hyperglycemia: The results of this study indicate that β-asarone attenuates HG-stimulated NLRP3 inflammasome-mediated lytic cell death and inactivates NF-κB in ARPE-19 cells, indicating its potential to treat hyperglycemia-induced DR.